A novel alpha- (N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production

Details for Australian Patent Application No. 2009342632 (hide)

Owner Bristol-Myers Squibb Company

Inventors Starrett, John E.; Gillman, Kevin W.; Olson, Richard E.

Agent A J Park

Pub. Number AU-A-2009342632

PCT Pub. Number WO2010/107435

Filing date 19 March 2009

Wipo publication date 23 September 2010

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/107435 Priority application(s): WO2010/107435

29 September 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Starrett Jr., John E.; Gillman, Kevin W. and Olson, Richard E.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009342637-Method and apparatus for reliable communications in underground and hazardous areas

2009342630-Addressable antibody arrays and methods of use